Karmanos

Karmanos, established in 1943 and headquartered in Detroit, Michigan, is a dedicated provider of comprehensive cancer care and research. Operating within Healthcare and Hospitals & Clinics, the organization focuses on advanced cancer treatment, scientific investigation programs, and clinical trials. With over eight decades of history, Karmanos has built a reputation for its commitment to patient outcomes and innovative approaches to oncology, aiming to advance cancer research and provide state-of-the-art care.

Karmanos operates across 29 locations, serving a broad patient base with specialized services including advanced diagnostics, genetic counseling, and testing, all supported by an expert team. The organization is deeply involved in conducting clinical trials to translate cutting-edge research into tangible treatment strategies. Employing between 1,000 and 5,000 individuals, Karmanos leverages its extensive infrastructure and skilled workforce to deliver high-quality healthcare. The company's revenue reached $149.0M, underscoring its significant operational scale and market presence in the cancer care landscape.

The competitive landscape for Karmanos includes prominent cancer institutes like Rutgers Cancer Institute of New Jersey and Fox Chase Cancer Center. Karmanos distinguishes itself through its integrated approach to cancer treatment, research, and patient support. Its long-standing presence and focus on specialized oncology services position it as a key player. To learn more about the dedicated professionals driving its mission, explore Meet Karmanos's team. This focus on expertise and comprehensive care is central to their ongoing efforts in combating cancer.